BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 30744940)

  • 1. A comparison of low and standard anti-coagulation regimens in extracorporeal membrane oxygenation.
    Raman J; Alimohamed M; Dobrilovic N; Lateef O; Aziz S
    J Heart Lung Transplant; 2019 Apr; 38(4):433-439. PubMed ID: 30744940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of anticoagulation strategies for veno-venous ECMO support in acute respiratory failure.
    Seeliger B; Döbler M; Friedrich R; Stahl K; Kühn C; Bauersachs J; Steinhagen F; Ehrentraut SF; Schewe JC; Putensen C; Welte T; Hoeper MM; Tiede A; David S; Bode C
    Crit Care; 2021 Jan; 24(1):701. PubMed ID: 33397427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venovenous Extracorporeal Membrane Oxygenation With Prophylactic Subcutaneous Anticoagulation Only: An Observational Study in More Than 60 Patients.
    Krueger K; Schmutz A; Zieger B; Kalbhenn J
    Artif Organs; 2017 Feb; 41(2):186-192. PubMed ID: 27256966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limb ischemia and bleeding in patients requiring venoarterial extracorporeal membrane oxygenation.
    Son AY; Khanh LN; Joung HS; Guerra A; Karim AS; McGregor R; Pawale A; Pham DT; Ho KJ
    J Vasc Surg; 2021 Feb; 73(2):593-600. PubMed ID: 32623105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleeding, Thrombosis, and Transfusion With Two Heparin Anticoagulation Protocols in Venoarterial ECMO Patients.
    Mazzeffi MA; Tanaka K; Roberts A; Rector R; Menaker J; Kon Z; Deatrick KB; Kaczorowski D; Griffith B; Herr D
    J Cardiothorac Vasc Anesth; 2019 May; 33(5):1216-1220. PubMed ID: 30181084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of two different extracorporeal membrane oxygenation systems: a single center report.
    Yu K; Long C; Hei F; Li J; Liu J; Ji B; Gao G; Zhang H; Song Y; Wang W
    Artif Organs; 2011 Jul; 35(7):733-7. PubMed ID: 21375546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation During Extracorporeal Membrane Oxygenation; Nafamostat Mesilate Versus Heparin.
    Lim JY; Kim JB; Choo SJ; Chung CH; Lee JW; Jung SH
    Ann Thorac Surg; 2016 Aug; 102(2):534-9. PubMed ID: 27083248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of bivalirudin versus heparin in adult extracorporeal membrane oxygenation anticoagulant therapy: A retrospective case-control study.
    Tong Y; Rouzhahong J; Zhou W; Wang R; Wang Y; Ren Y; Guo J; Li Y; Wang Z; Song Y
    Int J Artif Organs; 2023 Mar; 46(3):162-170. PubMed ID: 36600413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term venoarterial extracorporeal membrane oxygenation for massive endobronchial hemorrhage after pulmonary endarterectomy.
    Guth S; Wiedenroth CB; Wollenschläger M; Richter MJ; Ghofrani HA; Arlt M; Mayer E
    J Thorac Cardiovasc Surg; 2018 Feb; 155(2):643-649. PubMed ID: 29033041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of recombinant factor VIIa in patients under extracorporeal membrane oxygenation.
    Anselmi A; Guinet P; Ruggieri VG; Aymami M; Lelong B; Granry S; Malledant Y; Le Tulzo Y; Gueret P; Verhoye JP; Flecher E
    Eur J Cardiothorac Surg; 2016 Jan; 49(1):78-84. PubMed ID: 25908783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostasis, coagulation and thrombin in venoarterial and venovenous extracorporeal membrane oxygenation: the HECTIC study.
    Cartwright B; Bruce HM; Kershaw G; Cai N; Othman J; Gattas D; Robson JL; Hayes S; Alicajic H; Hines A; Whyte A; Chaikittisilpa N; Southwood TJ; Forrest P; Totaro RJ; Bannon PG; Dunkley S; Chen VM; Dennis M
    Sci Rep; 2021 Apr; 11(1):7975. PubMed ID: 33846433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of anticoagulation strategy and agents on extracorporeal membrane oxygenation therapy.
    Macielak S; Burcham P; Whitson B; Abdel-Rasoul M; Rozycki A
    Perfusion; 2019 Nov; 34(8):671-678. PubMed ID: 31057056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated partial thromboplastin time is a better trending tool in pediatric extracorporeal membrane oxygenation.
    Maul TM; Wolff EL; Kuch BA; Rosendorff A; Morell VO; Wearden PD
    Pediatr Crit Care Med; 2012 Nov; 13(6):e363-71. PubMed ID: 22940857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-xa directed protocol for anticoagulation management in children supported with extracorporeal membrane oxygenation.
    O'Meara LC; Alten JA; Goldberg KG; Timpa JG; Phillips J; Laney D; Borasino S
    ASAIO J; 2015; 61(3):339-44. PubMed ID: 25710768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracorporeal membrane oxygenation-hemostatic complications.
    Murphy DA; Hockings LE; Andrews RK; Aubron C; Gardiner EE; Pellegrino VA; Davis AK
    Transfus Med Rev; 2015 Apr; 29(2):90-101. PubMed ID: 25595476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional versus restricted anti-Xa-guided heparin protocol in adult patients undergoing extracorporeal membrane oxygenation.
    Alkazemi A; Eche IM; Adra M; Cabezas F; Patel P; Rick K; Grandin EW
    Artif Organs; 2022 Jan; 46(1):128-137. PubMed ID: 34725832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study evaluating a non-titrating, weight-based anticoagulation scheme for patients on veno-venous extracorporeal membrane oxygenation.
    Deatrick KB; Galvagno SM; Mazzeffi MA; Kaczoroswki DJ; Herr DL; Rector R; Hochberg E; Rabinowitz RP; Scalea TM; Menaker J
    Perfusion; 2020 Jan; 35(1):13-18. PubMed ID: 31122144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study.
    Pieri M; Agracheva N; Bonaveglio E; Greco T; De Bonis M; Covello RD; Zangrillo A; Pappalardo F
    J Cardiothorac Vasc Anesth; 2013 Feb; 27(1):30-4. PubMed ID: 23036625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unfractionated heparin activity measured by anti-factor Xa levels is associated with the need for extracorporeal membrane oxygenation circuit/membrane oxygenator change: a retrospective pediatric study.
    Irby K; Swearingen C; Byrnes J; Bryant J; Prodhan P; Fiser R
    Pediatr Crit Care Med; 2014 May; 15(4):e175-82. PubMed ID: 24622165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Anticoagulation and Circuit Technology on Complications During Extracorporeal Membrane Oxygenation.
    Niebler RA; Parker H; Hoffman GM
    ASAIO J; 2019; 65(3):270-276. PubMed ID: 29746314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.